Novel pressure-regulated deployment strategy for improving the safety and efficacy of balloon-expandable transcatheter aortic valves
نویسندگان
چکیده
Abstract Background The optimal method for balloon-expandable transcatheter heart valve (THV) deployment remains unknown. Current implantation protocols are volume-dependent and rely on ad-hoc filling of the apparatus without accounting annular wall tension during prosthesis expansion, predisposing patients to inconsistent clinical outcomes. During THV deployment, exerted by expanding is determined diameter balloon pressure (Laplace's Law). Objective We proposed tested a novel aimed at controlling resulting allow prosthesis-annulus apposition while preventing significant tissue injury. Methods 330 consecutive with severe native aortic stenosis who underwent between 2015–2020 were included. 106 considered high-risk rupture. THVs deployed until reaching pre-determined pressure; 4–4.5atm in earlier cases establish experience safety, later increasing 5–6.5atm most cases. Post-dilatation was performed reduce >mild angiographic regurgitation (PVR). Using biomechanical model, stress (tension) estimated each case assessed against recorded rates post-dilatation, ≥mild paravalvular (PVR) TTE, new PPM or LBBB Results Patients >3MPa (n=184) had reduced post-dilatation rate (p<0.001) final PVR (≥mild, p=0.014). Annular rupture occurred 2/3 >3.5MPa; no 102 ≤3.5MPa. Based these results, we defined target levels (3–3.5MPa) associated per size. within this range (n=136) 8.1% PPM, 12.5% LBBB, 12.7% mild ≥moderate PVR. Importantly, there an relationship volume stress. Conclusion Pressure-regulated simple, easily reproducible, safe effective method, regardless anatomical complexities. FUNDunding Acknowledgement Type funding sources: None. Model, vs strategy
منابع مشابه
Efficacy and safety of postdilatation to reduce paravalvular regurgitation during balloon-expandable transcatheter aortic valve replacement.
BACKGROUND Paravalvular regurgitation (PVR) is common after transcatheter aortic valve replacement (TAVR) and may be associated with adverse outcomes. Postdilatation (PD) has been proposed to treat PVR without being formally studied. We performed a study to evaluate the safety and efficacy of PD after balloon expandable TAVR. METHODS AND RESULTS Consecutive cases of TAVR were reviewed for cli...
متن کاملOptions for transcatheter aortic valve implantation: comparing self-expanding with balloon- expandable valves
Options for transcatheter aortic valve implantation: comparing self-expanding with balloonexpandable valves The advent of transcatheter aortic valve implantation (TAVI) has offered clinicians the option of managing patients with severe symptomatic aortic stenosis, who are at high operative risk, the possibility of replacing the aortic valve without requiring a full open-heart surgery. Two techn...
متن کاملRepeat transcatheter aortic valve implantation using a latest generation balloon-expandable device for treatment of failing transcatheter heart valves
BACKGROUND Paravalvular leakage (PVL) is a known complication of transcatheter aortic valve implantation (TAVI) and is associated with poor outcome. Besides balloon-post-dilatation, valve-in-valve (ViV) procedures can be taken into consideration to control this complication. Herein we present initial experience with use of the latest generation balloon-expandable Edwards Sapien 3® (S3) transcat...
متن کاملComparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.
BACKGROUND Transcatheter aortic valve implantation (TAVI) has emerged as an alternative to surgical aortic valve replacement for patients with symptomatic severe aortic stenosis (AS) who have a high surgical risk. In Taiwan, this is the first study reporting TAVI outcomes at a single center offering two different transcatheter heart valve technologies via four types of approaches. Our aim was t...
متن کاملComparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
IMPORTANCE Transcatheter aortic valve replacement (TAVR) is an effective treatment option for high-risk patients with severe aortic stenosis. Different from surgery, transcatheter deployment of valves requires either a balloon-expandable or self-expandable system. A randomized comparison of these 2 systems has not been performed. OBJECTIVE To determine whether the balloon-expandable device is...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2021
ISSN: ['2634-3916']
DOI: https://doi.org/10.1093/eurheartj/ehab724.2166